| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.83B | 13.87B | 12.92B | 11.35B | 6.62B | 4.75B |
| Gross Profit | 6.88B | 6.90B | 6.56B | 6.46B | 5.26B | 4.39B |
| EBITDA | 3.69B | 3.78B | 3.98B | 3.42B | 2.71B | 2.29B |
| Net Income | 2.21B | 2.26B | 2.37B | 2.17B | 1.67B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 272.60B | 277.83B | 248.56B | 221.59B | 195.96B | 180.47B |
| Cash, Cash Equivalents and Short-Term Investments | 70.44B | 83.78B | 77.17B | 68.87B | 57.13B | 57.37B |
| Total Debt | 15.59B | 12.80B | 4.82B | 5.13B | 5.13B | 3.71B |
| Total Liabilities | 257.53B | 262.63B | 234.48B | 208.95B | 184.92B | 170.03B |
| Stockholders Equity | 14.46B | 14.61B | 13.43B | 12.07B | 10.56B | 10.00B |
Cash Flow | ||||||
| Free Cash Flow | 1.01B | 2.97B | 1.23B | 1.15B | 3.26B | -1.27B |
| Operating Cash Flow | 1.13B | 3.04B | 1.47B | 1.33B | 3.43B | -1.10B |
| Investing Cash Flow | -22.22B | -21.58B | -10.15B | -8.73B | -14.40B | -10.68B |
| Financing Cash Flow | 14.87B | 25.44B | 18.17B | 19.34B | 10.04B | 11.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₪59.38B | 10.63 | 16.87% | 4.11% | 12.78% | 1.42% | |
70 Outperform | ₪110.13B | 10.89 | 15.67% | 3.70% | 17.99% | 9.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ₪101.07B | 10.78 | 15.13% | 3.54% | 20.24% | 17.76% | |
64 Neutral | ₪39.74B | 9.91 | 13.10% | 3.69% | 22.83% | -5.05% | |
58 Neutral | ₪24.69B | 11.18 | 15.81% | 4.57% | 21.26% | -5.22% |